1 Dept of Epidemiology and Preclinical Research, Translational Research Unit, National Institute for Infectious Diseases "L. Spallanzani", Rome, Italy.
2 South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa.
3 Division of Immunology, Dept of Pathology, University of Cape Town, Cape Town, South Africa.
4 Emerging Bacterial Pathogens Unit, Division of Immunology and Infectious Diseases, San Raffaele Scientific Institute, HSR, Milan, Italy.
5 Leiden University Medical Center, Leiden, The Netherlands.
6 Istituto Villa Marelli, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
7 Tuberculosis and Hepatitis Programme, Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
8 Dept of Epidemiology and Preclinical Research, Translational Research Unit, National Institute for Infectious Diseases "L. Spallanzani", Rome, Italy delia.goletti@inmi.it.